Skip to main content

Table 1 Standard dosing and frequency reference

From: Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

TNFi medication

Standard dose (mg)

Standard dose frequency (weeks)

Adalimumab

40 mg (if ≥30 kg) subq

Every 2 weeks

20 mg (if <30 kg) subq

 

Certolizumab

50 mg (if <40 kg) subq

Every 2 weeks

100 mg (if ≥40 kg) subq

 

Etanercept

0.8 mg/kg/dose, max 50 kg subq

Weekly

Golimumab

80 mg/m2 IV

Every 8 weeks (IV)

30 mg/m2, max 50 mg subq

Every 4 weeks (subq)

Infliximab

5–10 mg/kg/dose IV

Every 4–8 weeks